Leo Mortimer

Leo Mortimer is a Scientist I at Inotiv since October 2022, specializing in biotherapeutics, where responsibilities include developing and validating ligand binding assays and flow cytometry panels for phenotyping. Previously, Leo has served as an Associate Scientist at BioNTech SE, focusing on peptide synthesis for cancer research, and as a Senior Research Associate at Kite Pharma. Further experiences include roles as a Senior Data Reviewer at Eurofins Lancaster Laboratories, Biochemist at Advance Testing Laboratory, and Peptide Chemist at Advanced Testing Laboratory, alongside a range of positions in earlier stages of the career including research technician and clinical molecular genetics technician. Leo holds an MS in Biology from Duquesne University, an MBA in Marketing from the University of Pittsburgh, and a BA in Biology from Thiel College.